The London Clinic has completed a two-year, £4 million refit and redesign of its in-house blood sciences pathology laboratory, which now boasts gold-standard equipment. The use of ground-breaking technology in the diagnosis of cancer conditions will enable a far greater volume of accurate tests to be processed, around the clock, seven days a week.
The official opening of the pathology laboratory was held recently at 120 Harley Street, in partnership with biochemistry equipment supplier QuidelOrtho. The event marked a significant development step change with more innovation to come.
The new pathology laboratory equipment benefits Clinic patients, and external commercial clients with the following capabilities to provide the greatest flexibility of service, and simplify daily routines for maximum efficiency.
New technology at the laboratory includes:
- ALEX 2 Allergy Explorer - rapidly tests for up to 300 allergens simultaneously and provides a wide-ranging analysis from a very small sample volume.
- Automatic Chemiluminescence Immunoassay Analyzer BioCLIA 500 - combines chemiluminescence technology, immune reaction technology and magnetic separation technology to support the diagnosis of autoimmune antiphospholipid syndrome testing, autoimmune celiac disease screening and vasculitis assay.
- Gemini – used for anti-thyroid peroxidase antibody (anti-TPO) and anti-thyroglobulin antibody (anti-TG) testing. The Gemini is available as either an EIA (enzyme immunoassay) processing instrument or as the dual technology Gemini Combo which combines its well-proven EIA processing with highly sophisticated IFA (immunofluorescence assay) applications.
- Installation of track automation - for priority-based test profiles resulting in faster processing and turnaround times for clinical effectiveness
- Vendor database - for the collection and analysis of clinical data
- Cellavision - automates and simplifies the process of performing blood cell morphology. The system leverages high-speed robotics and digital imaging to automatically locate and capture high-quality images of cells and allows clinicians to remotely review the slides from offsite.
- A range of risk reduction mechanisms to maximise the accuracy of reporting test results.
Reza Mirza, Head of Pathology, at The London Clinic, said: “The investment in our dedicated in-house pathology service means we have total confidence in meeting our clinical colleagues’ and customers' high expectations. We understand that as a patient waiting for a diagnosis, or a medical professional who needs a speedy result to start their patient’s treatment, time is always of the essence. Our new path laboratory technology enables us to analyse an even larger repertoire of tests in-house. This is key to the fast turnaround of results now oncology patients can receive same-day blood results.
Paul Hackworth, Director at QuidelOrtho said: “We are very pleased to be partnering with The London Clinic on this exciting laboratory refit. Diagnostic tests are the cornerstone for medical treatment and with the installation of state-of-the-art analysers capable of running high-accuracy tests. The London Clinic offer patients the best care possible.”
The London Clinic is one of the UK's largest private hospitals and was granted charitable status in 1935. The pathology laboratory development is part of an ongoing programme by the Clinic to invest surplus income as part of its charitable purpose to continuously update equipment, support research and train its staff to improve health outcomes for Clinic patients and to benefit the local community.
